16/02/2026
🧪 New Research Insight: Inflammation May Be the Missing Prognostic Signal in CKD
What if kidney disease progression isn’t just about eGFR… but about inflammatory identity?
A large prospective study in stage 3 CKD followed patients for up to 10 years and found that specific inflammatory cytokines strongly predicted:
📌 Faster worsening of albuminuria
📌 Progression to kidney failure
📌 Cardiovascular events
📌 All-cause mortality
The strongest signals came from TNF-α, GDF-15, and IL-22.
Researchers identified six distinct inflammatory “profiles.”
Patients with the highest inflammatory burden had the worst renal and cardiovascular outcomes, while those with low cytokine activity had the slowest CKD progression and best survival.
Even more concerning:
➡️ Many patients shifted into more inflammatory profiles over time, suggesting that inflammation accelerates as CKD advances.
This raises an uncomfortable but necessary question:
Are we underestimating inflammation as a primary driver of kidney decline?
And if so, why aren’t we measuring it more intentionally?
These findings support a future where CKD care moves beyond one-size-fits-all staging and toward:
✔️ Early identification of high-risk inflammatory phenotypes
✔️ More personalized, anti-inflammatory strategies
✔️ Better prediction of who will progress — and who may not
We’d love your thoughts:
📌Should inflammatory biomarkers play a larger role in CKD risk stratification?
📌 How might this change how we monitor or treat earlier-stage CKD?
📌 What anti-inflammatory strategies have you found most impactful in practice?
Read the study here: [https://f.mtr.cool/ixhqdrhfxf
Let’s discuss below 👇